BARKLEY PSYCHIATRIC DISORDERS
PRACTICE EXAM Comprehensive 200-
Question Practice Examination – New
Edition
INTRODUCTION
The Barkley Psychiatric Disorders Practice Exam is a
comprehensive, standardized practice examination designed to
evaluate the clinical knowledge, diagnostic reasoning, and
management skills required for safe, effective psychiatric-
mental health advanced practice nursing. This examination
mirrors the content blueprint of the ANCC Psychiatric-Mental
Health Nurse Practitioner (PMHNP-BC) certification exam
and emphasizes the clinical judgment required for
independent practice.
This examination is structured around the core psychiatric
domains:
• Neurobiology and Pathophysiology
• Psychiatric Assessment and Diagnosis
• Psychopharmacology
• Psychotherapy and Therapeutic Modalities
• Mood Disorders
• Anxiety Disorders
• Psychotic Disorders
• Trauma and Stressor-Related Disorders
• Personality Disorders
,• Substance Use Disorders
• Child and Adolescent Psychiatric Disorders
• Geriatric Psychiatric Disorders
• Ethics, Legal, and Professional Issues
Each of the 200 questions is presented in a clinical scenario-
based format, requiring the psychiatric NP to apply the
diagnostic reasoning process (Subjective Data, Objective Data,
Assessment/Differential Diagnosis, Plan/Management) and
evidence-based psychiatric guidelines.
Answer Format:
• Correct answers and detailed explanations are presented in
italics.
• Rationales and clinical reasoning are presented in bold.
This examination is intended for PMHNP students preparing for
certification, practicing psychiatric NPs seeking continuing
education, and educators developing comprehensive
assessment tools.
TABLE OF CONTENTS
Section Content Area Question Ran
I Neurobiology and Pathophysiology 1–20
II Psychiatric Assessment and Diagnosis 21–45
III Psychopharmacology 46–80
IV Psychotherapy and Therapeutic Modalities 81–100
,Section Content Area Question Ran
V Mood Disorders 101–125
VI Anxiety Disorders 126–145
VII Psychotic Disorders 146–165
VIII Trauma and Stressor-Related Disorders 166–175
IX Personality Disorders 176–185
X Substance Use Disorders 186–195
XI Child, Adolescent, and Geriatric Psychiatry 196–200
Answer Key & Rationales 1–200
SECTION I: NEUROBIOLOGY AND PATHOPHYSIOLOGY
(Questions 1–20)
Question 1
Which neurotransmitter is primarily associated with the positive
symptoms of schizophrenia?
A. Serotonin
B. Dopamine
C. Norepinephrine
D. GABA
Answer: B
, Dopamine hyperactivity in the mesolimbic pathway is associated
with positive symptoms of schizophrenia (hallucinations,
delusions).
Rationale: Serotonin (A) is associated with mood and
anxiety. Norepinephrine (C) is associated with arousal and
mood. GABA (D) is the primary inhibitory neurotransmitter.
Dopamine (B) is correct.
Question 2
Which brain structure is primarily associated with fear
processing and PTSD hyperarousal?
A. Hippocampus
B. Amygdala
C. Prefrontal cortex
D. Cerebellum
Answer: B
The amygdala is implicated in fear processing and threat
detection, and is hyperactive in PTSD.
Rationale: The hippocampus (A) is associated with memory.
The prefrontal cortex (C) is associated with executive
function. The cerebellum (D) is associated with
coordination. The amygdala (B) is correct.
PRACTICE EXAM Comprehensive 200-
Question Practice Examination – New
Edition
INTRODUCTION
The Barkley Psychiatric Disorders Practice Exam is a
comprehensive, standardized practice examination designed to
evaluate the clinical knowledge, diagnostic reasoning, and
management skills required for safe, effective psychiatric-
mental health advanced practice nursing. This examination
mirrors the content blueprint of the ANCC Psychiatric-Mental
Health Nurse Practitioner (PMHNP-BC) certification exam
and emphasizes the clinical judgment required for
independent practice.
This examination is structured around the core psychiatric
domains:
• Neurobiology and Pathophysiology
• Psychiatric Assessment and Diagnosis
• Psychopharmacology
• Psychotherapy and Therapeutic Modalities
• Mood Disorders
• Anxiety Disorders
• Psychotic Disorders
• Trauma and Stressor-Related Disorders
• Personality Disorders
,• Substance Use Disorders
• Child and Adolescent Psychiatric Disorders
• Geriatric Psychiatric Disorders
• Ethics, Legal, and Professional Issues
Each of the 200 questions is presented in a clinical scenario-
based format, requiring the psychiatric NP to apply the
diagnostic reasoning process (Subjective Data, Objective Data,
Assessment/Differential Diagnosis, Plan/Management) and
evidence-based psychiatric guidelines.
Answer Format:
• Correct answers and detailed explanations are presented in
italics.
• Rationales and clinical reasoning are presented in bold.
This examination is intended for PMHNP students preparing for
certification, practicing psychiatric NPs seeking continuing
education, and educators developing comprehensive
assessment tools.
TABLE OF CONTENTS
Section Content Area Question Ran
I Neurobiology and Pathophysiology 1–20
II Psychiatric Assessment and Diagnosis 21–45
III Psychopharmacology 46–80
IV Psychotherapy and Therapeutic Modalities 81–100
,Section Content Area Question Ran
V Mood Disorders 101–125
VI Anxiety Disorders 126–145
VII Psychotic Disorders 146–165
VIII Trauma and Stressor-Related Disorders 166–175
IX Personality Disorders 176–185
X Substance Use Disorders 186–195
XI Child, Adolescent, and Geriatric Psychiatry 196–200
Answer Key & Rationales 1–200
SECTION I: NEUROBIOLOGY AND PATHOPHYSIOLOGY
(Questions 1–20)
Question 1
Which neurotransmitter is primarily associated with the positive
symptoms of schizophrenia?
A. Serotonin
B. Dopamine
C. Norepinephrine
D. GABA
Answer: B
, Dopamine hyperactivity in the mesolimbic pathway is associated
with positive symptoms of schizophrenia (hallucinations,
delusions).
Rationale: Serotonin (A) is associated with mood and
anxiety. Norepinephrine (C) is associated with arousal and
mood. GABA (D) is the primary inhibitory neurotransmitter.
Dopamine (B) is correct.
Question 2
Which brain structure is primarily associated with fear
processing and PTSD hyperarousal?
A. Hippocampus
B. Amygdala
C. Prefrontal cortex
D. Cerebellum
Answer: B
The amygdala is implicated in fear processing and threat
detection, and is hyperactive in PTSD.
Rationale: The hippocampus (A) is associated with memory.
The prefrontal cortex (C) is associated with executive
function. The cerebellum (D) is associated with
coordination. The amygdala (B) is correct.
